Nuclear Medicine Equipment Market Global Report 2026

The nuclear medicine equipment market size has grown strongly in recent years. It will grow from $6.05 billion in 2025 to $6.35 billion in 2026 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to the growth of the aging population, rising cancer prevalence, increasing adoption of diagnostic imaging, expansion of hospital infrastructure, and growing government funding for nuclear medicine.

The nuclear medicine equipment market size is expected to see steady growth in the next few years. It will grow to $7.62 billion in 2030 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to growing adoption of theranostics, increasing demand for precision medicine, technological advancements in hybrid imaging, rising cardiovascular disease burden, and expansion of imaging centers in emerging markets. Major trends in the forecast period include advanced hybrid imaging systems, expansion of theranostics applications, increasing adoption of personalized nuclear diagnostics, growing focus on radiation dose optimization, and rising demand for outpatient nuclear imaging services.

The growing electricity consumption worldwide is expected to propel the growth of the nuclear fuel market going forward. Electricity consumption refers to the total amount of electrical energy utilized by consumers over a specified period. The growth in electricity consumption worldwide can be attributed to several factors, including industrial and manufacturing electrification, population growth, increased technology usage, and the electrification of transportation. Nuclear fuel is valuable for electricity generation because of its high energy density, low greenhouse gas emissions, reliability, and ability to provide continuous baseload power. For instance, in June 2025, according to Eurostat, a Luxembourg-based government agency, in 2023, the total electricity supply in the EU increased by 2.0% compared with 2023. Furthermore, 47.3% of electricity in the EU was generated from renewable energy, compared with 44.9% in 2023. Therefore, growing electricity consumption worldwide is driving the growth of the nuclear fuel market.

Leading companies operating in the nuclear medicine equipment market are focused on developing advanced products, such as PET/CT scanners, to provide highly detailed, functional images of the body's metabolic processes. A PET/CT scanner is an advanced imaging device used in nuclear medicine that combines two technologies, positron emission tomography and computed tomography. This dual-modality scanner provides functional and anatomical imaging in a single session, allowing doctors to detect and diagnose various conditions more accurately. For example, in June 2024, Siemens Healthineers, a Germany-based healthcare company, launched the Biograph Trinion PET/CT scanner. The PET scanner features a unique, scalable axial field-of-view design, allowing on-site technological upgrades without requiring costly room renovations or disrupting workflow. It features a lutetium oxyorthosilicate crystal detector that offers high spatial resolution and ultrafast time-of-flight performance of 239 picoseconds, enhancing small lesion detectability and providing adequate sensitivity of up to 128 cps/kBq. This results in rapid scans with reduced patient radiation doses. Additionally, the Biograph Trinion includes a new air-cooled digital detector, simplifying installation compared with traditional water-cooled systems.

In November 2023, Mirion Technologies Inc., a US-based company specializing in radiation detection, measurement, and protection equipment, acquired ec2 Software Solutions for an undisclosed amount. Through this acquisition, Mirion Technologies sought to enhance its nuclear medicine and molecular imaging portfolio by incorporating ec2’s advanced software solutions and strengthening its ability to deliver comprehensive imaging and data management solutions. ec² Software Solutions is a US-based provider of nuclear medicine equipment.

Major companies operating in the nuclear medicine equipment market are Fujifilm Holdings Corporation, Koninklijke Philips N.V., General Electric Company, Shimadzu Corporation, Mallinckrodt Pharmaceuticals, Curium Pharma, Cardinal Health Inc., Canon Medical Systems Corporation, Digirad Corporation, TTG Imaging Solutions, Biodex Medical Systems Inc., Spectrum Dynamics Medical, Mediso Ltd., Cyclopharm Limited, Siemens Healthineers AG, Capintec Inc., Toshiba Medical Systems Corporation, Elysia-Raytest, DDD-Diagnostic A/S, MILabs B.V.

North America was the largest region in the nuclear medicine equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nuclear medicine equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 1-3 business days.